Results 21 to 30 of about 1,091,366 (233)

Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin. [PDF]

, 2012
Sirtuins (SIRTs) and poly(ADP-ribose) polymerases (PARPs), NAD(+)-dependent enzymes, link cellular energy status with responses to environmental stresses.
Benavente, Claudia A, Jacobson, Elaine L, Schnell, Stephanie A   +2 more
core   +7 more sources

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

Vaccines, 2016
The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy.
Viktor Umansky, Carolin Blattner, Christoffer Gebhardt, Jochen Utikal   +3 more
doaj   +1 more source

Clinical, dermoscopic and histopathologic findings of retiform hemangioendothelioma

Dermatology Practical & Conceptual, 2013
Retiform hemangioendothelioma (RH) is an uncommon vascular neoplasm of borderline malignancy that clinically develops as a solitary, gradually enlarging exophytic mass, nodule or plaque, most often on the lower limbs, upper limbs and trunk.
Amanda Mota, Giuseppe Argenziano, Iris Zalaudek, Simonetta Piana, Caterina Longo, Elvira Moscarella, Aimilios Lallas   +6 more
doaj   +1 more source

Discovery Radiomics via Deep Multi-Column Radiomic Sequencers for Skin Cancer Detection [PDF]

, 2017
While skin cancer is the most diagnosed form of cancer in men and women, with more cases diagnosed each year than all other cancers combined, sufficiently early diagnosis results in very good prognosis and as such makes early detection crucial.
Shafiee, Mohammad Javad, Wong, Alexander
core   +3 more sources

SKIN CANCERS [PDF]

Southern Medical Journal, 1914
n ...
openaire   +2 more sources

Skin cancers and their risk factors in older persons : a population-based study [PDF]

, 2022
Background: The number of skin cancer is increasing rapidly. However, little is known about the risk factors of skin cancer in older persons. Our objectives were to determine the risk factors for skin cancer or its precursors in an older population. More
Huilaja, Laura, Jokelainen, Jari, Keinänen-Kiukaanniemi, Sirkka, Sinikumpu, Suvi-Päivikki   +3 more
core   +1 more source

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

Journal for ImmunoTherapy of Cancer, 2018
Background Paraneoplastic hyperleucocytosis (PH) is sporadically seen in patients with advanced solid tumors. Case presentation We report a female patient with disseminated melanoma metastases.
Thilo Gambichler, E. Stockfleth, L. Susok   +2 more
doaj   +1 more source

Skin Lesion Analyser: An Efficient Seven-Way Multi-Class Skin Cancer Classification Using MobileNet

, 2020
Skin cancer, a major form of cancer, is a critical public health problem with 123,000 newly diagnosed melanoma cases and between 2 and 3 million non-melanoma cases worldwide each year. The leading cause of skin cancer is high exposure of skin cells to UV
A Esteva, A Khosla, A Krizhevsky, Barbara Rosado, BO Cakir, CA Morton, D Silver, D. Piccolo, DM Parkin, G Argenziano, H Kittler, HK Koh, Howard W. Rogers, HW Rogers, JA Neville, Jeremy Kawahara, K Weiss, L Liu, M Burroni, ME Vestergaard, Michael Binder, O Russakovsky, P Ding, P Tschandl, RL Siegel, RS Stern, RS Stern, V Mnih, Y LeCun   +28 more
core   +1 more source

Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response

Stem Cell Reports, 2017
A point mutation in the BRAF gene, leading to a constitutively active form of the protein, is present in 45%–60% of patients and acts as a key driver in melanoma.
Mathias Bernhardt, Daniel Novak, Yassen Assenov, Elias Orouji, Nathalie Knappe, Kasia Weina, Maike Reith, Lionel Larribere, Christoffer Gebhardt, Christoph Plass, Viktor Umansky, Jochen Utikal   +11 more
doaj   +1 more source

Management of skin-sparing mastectomy: Results of a survey of German Hospitals [PDF]

, 2006
Background: The aim of this study was to evaluate the current management of skin-sparing mastectomy in German hospitals and to determine its oncologic safety.
Dian, D., Friese, K., Hemminger, G., Janni, W., Jänicke, F.   +4 more
core   +1 more source